Identification of Drug-Specific Public TCR Driving Severe Cutaneous Adverse Reactions
Nature Communications - United Kingdom
doi 10.1038/s41467-019-11396-2
Full Text
Open PDFAbstract
Available in full text
Date
August 8, 2019
Authors
Publisher
Springer Science and Business Media LLC